Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix Makes $5M Investment in Ingenuity Systems, Signs Software Distribution Deal

NEW YORK, Aug. 11 (GenomeWeb News) - Affymetrix has signed a distribution agreement with Ingenuity Systems for its Pathways Analysis product, and has made a $5 million equity investment in the Mountain View, Calif.-based software company.


Under the agreement, Affymetrix will offer the Pathways Analysis software to its customers. Pathways Analysis is a web-based program that will allow Affymetrix customers the ability to connect gene expression to biologically relevant networks. It is web-based and has visualization tools and a database of annotations from life science journals.


The product is currently being beta tested and will have a limited release in September.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.